ADDvise explores potential divestment of its subsidiary Germa
ADDvise is exploring the possibility of divesting its subsidiary AB Germa. Germa has shifted its focus primarily towards defense equipment, which falls outside of ADDvise’s core business within life science. ADDvise is therefore evaluating options to find a new owner who can further develop Germa and maximize its full potential within the defense segment. Since ADDvise acquired the company in 2017, Germa has experienced strong growth. At the time of acquisition, Germa had revenues of SEK 30 million with an EBITDA of SEK 3.5 million. As of the rolling twelve-month period ending September